How it works and why it could help with exercise challenges. Plus, how diaTribe readers can try it for free
Type 1 Diabetes News
Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels.
37 readers recommended
50 readers recommended
Third diabetes partnership for Fitbit, focused on integrating activity and sleep data with diabetes data on the phone and watch
100 readers recommended
Device Updates from Abbott, Dexcom, Insulet, Medtronic, and Tandem
46 readers recommended
Health Canada has approved the once-daily insulin for adults with type 1 and type 2 diabetes
47 readers recommended
Ease, comfort, and actionable patterns, but some challenges with insurance coverage
57 readers recommended
Get weekly email and phone notifications summarizing time-in-range and glucose trends from the updated Dexcom Clarity app
58 readers recommended
Breaking down employer-based health insurance, employee health benefits, and employee rights for people with diabetes
148 readers recommended
What are the options for approximately 90,000 Animas pumpers worldwide and for others considering a new pump? What does it mean for the pump market and patient choice?
30 readers recommended
A workshop hosted by the JDRF and Helmsley Charitable Trust brought together leaders in the field to discuss opportunities and advances in the treatment and possible...
54 readers recommended
The most popular diabetes app in the world, mySugr offers coaching and tools to track blood sugar, medications, exercise, and “makes diabetes suck less”
48 readers recommended
How to get cheaper drugs, find discount programs, get free care in clinical trials, and more
55 readers recommended
Lilly announces new program, in partnership with Express Scripts, to provide insulin directly to people with diabetes and high out of pocket drug expenses
42 readers recommended
First trial next month, launch expected in 2-3 years; Dexcom CGM included; a big commitment to diabetes tech innovation from an insulin company
102 readers recommended
Research presented at ADA’s 2017 conference shows exciting advances in a host of diabetes drugs – including heart benefits, improved glucose control, lower cholesterol,...
48 readers recommended
Trial results testing sotagliflozin and Farxiga in type 1 diabetes show greater A1c lowering and weight loss, plus continued conversation about small risk of DKA
25 readers recommended
A major call for creativity, urgency, and new approaches to behavior change from expert panelists at SXSW 2017
53 readers recommended
Research reveals improved A1c and weight loss benefits for people with type 1 diabetes on sotagliflozin, but a slightly increased risk of DKA
49 readers recommended
Comparing Medtronic’s MiniMed 670G to injections and pumps in people with type 1 diabetes, with and without CGM; enrollment to open in May at some trial locations
51 readers recommended
How I avoid highs, prevent lows, and stop blood sugar frustration during exercise
29 readers recommended
Hosted by TCOYD in San Diego, CA from June 23-25; early-bird registration until March 23